{"status":"ok","message-type":"work","message-version":"1.0.0","message":{"indexed":{"date-parts":[[2025,11,6]],"date-time":"2025-11-06T08:50:06Z","timestamp":1762419006871,"version":"build-2065373602"},"reference-count":23,"publisher":"Elsevier BV","issue":"5","license":[{"start":{"date-parts":[[2023,9,1]],"date-time":"2023-09-01T00:00:00Z","timestamp":1693526400000},"content-version":"tdm","delay-in-days":0,"URL":"https:\/\/www.elsevier.com\/tdm\/userlicense\/1.0\/"},{"start":{"date-parts":[[2023,9,1]],"date-time":"2023-09-01T00:00:00Z","timestamp":1693526400000},"content-version":"tdm","delay-in-days":0,"URL":"https:\/\/www.elsevier.com\/legal\/tdmrep-license"}],"content-domain":{"domain":["clinicalkey.com","clinicalkey.com.au","clinicalkey.es","clinicalkey.fr","clinicalkey.jp","elsevier.es","elsevier.com","sciencedirect.com"],"crossmark-restriction":true},"short-container-title":["Revista Espa\u00f1ola de Medicina Nuclear e Imagen Molecular (English Edition)"],"published-print":{"date-parts":[[2023,9]]},"DOI":"10.1016\/j.remnie.2023.04.007","type":"journal-article","created":{"date-parts":[[2023,4,25]],"date-time":"2023-04-25T13:01:02Z","timestamp":1682427662000},"page":"302-309","update-policy":"https:\/\/doi.org\/10.1016\/elsevier_cm_policy","source":"Crossref","is-referenced-by-count":1,"title":["Absolute quantification of myocardial uptake of 99mTc-DPD in patients with cardiac amyloidosis due to transthyretin deposits (ATTR)"],"prefix":"10.1016","volume":"42","author":[{"given":"Francisco","family":"Sebasti\u00e1n Palacid","sequence":"first","affiliation":[],"role":[{"role":"author","vocabulary":"crossref"}]},{"given":"Noelia","family":"\u00c1lvarez Mena","sequence":"additional","affiliation":[],"role":[{"role":"author","vocabulary":"crossref"}]},{"given":"Rosanna","family":"del Carmen Zambrano Infantino","sequence":"additional","affiliation":[],"role":[{"role":"author","vocabulary":"crossref"}]},{"given":"Mar\u00eda","family":"Garc\u00eda Arag\u00f3n","sequence":"additional","affiliation":[],"role":[{"role":"author","vocabulary":"crossref"}]},{"given":"Mercedes","family":"Alonso Rodr\u00edguez","sequence":"additional","affiliation":[],"role":[{"role":"author","vocabulary":"crossref"}]},{"given":"Berta","family":"P\u00e9rez L\u00f3pez","sequence":"additional","affiliation":[],"role":[{"role":"author","vocabulary":"crossref"}]},{"given":"Claudia","family":"Gamazo Laherr\u00e1n","sequence":"additional","affiliation":[],"role":[{"role":"author","vocabulary":"crossref"}]},{"given":"Mar\u00eda Jes\u00fas","family":"Gonz\u00e1lez Soto","sequence":"additional","affiliation":[],"role":[{"role":"author","vocabulary":"crossref"}]},{"given":"Ricardo","family":"Ruano P\u00e9rez","sequence":"additional","affiliation":[],"role":[{"role":"author","vocabulary":"crossref"}]}],"member":"78","reference":[{"issue":"8","key":"10.1016\/j.remnie.2023.04.007_bib0005","doi-asserted-by":"crossref","first-page":"547","DOI":"10.1002\/clc.4960210804","article-title":"A review of the amyloidoses that infiltrate the heart","volume":"21","author":"McCarthy","year":"1998","journal-title":"Clin Cardiol"},{"issue":"2","key":"10.1016\/j.remnie.2023.04.007_bib0010","doi-asserted-by":"crossref","first-page":"e000364","DOI":"10.1161\/JAHA.111.000364","article-title":"Updates in cardiac amyloidosis: a review","volume":"1","author":"Banypersad","year":"2012","journal-title":"J Am Heart Assoc"},{"issue":"7","key":"10.1016\/j.remnie.2023.04.007_bib0015","doi-asserted-by":"crossref","first-page":"733","DOI":"10.1038\/gim.2016.200","article-title":"Transthyretin V122I (pV142I)* cardiac amyloidosis: an age-dependent autosomal dominant cardiomyopathy too common to be overlooked as a cause of significant heart disease in elderly African Americans","volume":"19","author":"Buxbaum","year":"2017","journal-title":"Genet Med"},{"issue":"4","key":"10.1016\/j.remnie.2023.04.007_bib0020","doi-asserted-by":"crossref","first-page":"463","DOI":"10.1016\/j.jacc.2017.11.037","article-title":"Prevalence of cardiac amyloidosis in patients referred for transcatheter aortic valve replacement","volume":"71","author":"Scully","year":"2018","journal-title":"J Am Coll Cardiol"},{"issue":"38","key":"10.1016\/j.remnie.2023.04.007_bib0025","doi-asserted-by":"crossref","first-page":"2585","DOI":"10.1093\/eurheartj\/ehv338","article-title":"Wild-type transthyretin amyloidosis as a cause of heart failure with preserved ejection fraction","volume":"36","author":"Gonz\u00e1lez-L\u00f3pez","year":"2015","journal-title":"Eur Heart J"},{"issue":"Suppl 2","key":"10.1016\/j.remnie.2023.04.007_bib0030","doi-asserted-by":"crossref","first-page":"s30","DOI":"10.7861\/clinmedicine.18-2-s30","article-title":"Cardiac amyloidosis","volume":"18","author":"Martinez-Naharro","year":"2018","journal-title":"Clin Med (Lond)"},{"issue":"12","key":"10.1016\/j.remnie.2023.04.007_bib0035","doi-asserted-by":"crossref","first-page":"1344","DOI":"10.1093\/ehjci\/jew325","article-title":"Prognostic utility of the Perugini grading of 99mTc-DPD scintigraphy in transthyretin (ATTR) amyloidosis and its relationship with skeletal muscle and soft tissue amyloid","volume":"18","author":"Hutt","year":"2017","journal-title":"Eur Heart J Cardiovasc Imaging"},{"issue":"3","key":"10.1016\/j.remnie.2023.04.007_bib0040","doi-asserted-by":"crossref","first-page":"203","DOI":"10.1080\/13506129.2018.1520087","article-title":"Quantitation of 99mTc-DPD uptake in patients with transthyretin-related cardiac amyloidosis","volume":"25","author":"Ross","year":"2018","journal-title":"Amyloid"},{"issue":"6","key":"10.1016\/j.remnie.2023.04.007_bib0045","doi-asserted-by":"crossref","first-page":"2483","DOI":"10.1007\/s12350-021-02715-6","article-title":"An optimized imaging protocol for [99mTc]Tc-DPD scintigraphy and SPECT\/CT quantification in cardiac transthyretin (ATTR) amyloidosis","volume":"28","author":"Schatka","year":"2021","journal-title":"J Nucl Cardiol"},{"issue":"6","key":"10.1016\/j.remnie.2023.04.007_bib0050","doi-asserted-by":"crossref","first-page":"1353","DOI":"10.1016\/j.jcmg.2020.03.020","article-title":"DPD quantification in cardiac amyloidosis: a novel imaging biomarker","volume":"13","author":"Scully","year":"2020","journal-title":"JACC Cardiovasc Imaging"},{"issue":"11","key":"10.1016\/j.remnie.2023.04.007_bib0055","doi-asserted-by":"crossref","first-page":"3446","DOI":"10.3390\/jcm9113446","article-title":"In vivo quantification of myocardial amyloid deposits in patients with suspected transthyretin-related amyloidosis (ATTR)","volume":"9","author":"Wollenweber","year":"2020","journal-title":"J Clin Med"},{"issue":"5","key":"10.1016\/j.remnie.2023.04.007_bib0060","doi-asserted-by":"crossref","first-page":"1464","DOI":"10.1007\/s12350-019-01935-1","article-title":"The current status of quantitative SPECT\/CT in the assessment of transthyretin cardiac amyloidosis","volume":"27","author":"Ramsay","year":"2020","journal-title":"J Nucl Cardiol"},{"issue":"24","key":"10.1016\/j.remnie.2023.04.007_bib0065","doi-asserted-by":"crossref","first-page":"2404","DOI":"10.1161\/CIRCULATIONAHA.116.021612","article-title":"Nonbiopsy diagnosis of cardiac transthyretin amyloidosis","volume":"133","author":"Gillmore","year":"2016","journal-title":"Circulation"},{"issue":"2","key":"10.1016\/j.remnie.2023.04.007_bib0070","doi-asserted-by":"crossref","first-page":"61","DOI":"10.1007\/s13139-020-00681-4","article-title":"Nuclear imaging for cardiac amyloidosis: bone scan, SPECT\/CT, and amyloid-targeting PET","volume":"55","author":"Paeng","year":"2021","journal-title":"Nucl Med Mol Imaging"},{"issue":"4","key":"10.1016\/j.remnie.2023.04.007_bib0075","doi-asserted-by":"crossref","first-page":"e18905","DOI":"10.1097\/MD.0000000000018905","article-title":"99mTc-DPD scintigraphy and SPECT\/CT in patients with AL and ATTR type amyloidosis: potential clinical implications","volume":"99","author":"Lee","year":"2020","journal-title":"Medicine (Baltimore)"},{"issue":"7","key":"10.1016\/j.remnie.2023.04.007_bib0080","doi-asserted-by":"crossref","first-page":"1407","DOI":"10.1007\/s00259-019-04290-y","article-title":"Detection of cardiac amyloidosis with 18F-Florbetaben-PET\/CT in comparison to echocardiography, cardiac MRI and DPD-scintigraphy","volume":"46","author":"Kircher","year":"2019","journal-title":"Eur J Nucl Med Mol Imaging"},{"key":"10.1016\/j.remnie.2023.04.007_bib0085","doi-asserted-by":"crossref","DOI":"10.3389\/fcvm.2021.693194","article-title":"Pilot study of F18-Florbetapir in the early evaluation of cardiac amyloidosis","volume":"8","author":"Sperry","year":"2021","journal-title":"Front Cardiovasc Med"},{"issue":"5","key":"10.1016\/j.remnie.2023.04.007_bib0090","doi-asserted-by":"crossref","first-page":"1456","DOI":"10.1007\/s12350-019-01893-8","article-title":"Quantitative 99mTc-DPD SPECT\/CT in patients with suspected ATTR cardiac amyloidosis: feasibility and correlation with visual scores","volume":"27","author":"Caobelli","year":"2020","journal-title":"J Nucl Cardiol"},{"key":"10.1016\/j.remnie.2023.04.007_bib0095","first-page":"A16","article-title":"3 SPECT\/CT quantification of DPD scintigraphy in cardiac amyloid","volume":"104","author":"Scully","year":"2018","journal-title":"Heart"},{"issue":"1","key":"10.1016\/j.remnie.2023.04.007_bib0100","doi-asserted-by":"crossref","first-page":"17","DOI":"10.1186\/s41824-018-0035-1","article-title":"Tc-HDP quantitative SPECT\/CT in transthyretin cardiac amyloid and the development of a reference interval for myocardial uptake in the non-affected population","volume":"2","author":"Ramsay","year":"2018","journal-title":"Eur J Hybrid Imaging"},{"issue":"1","key":"10.1016\/j.remnie.2023.04.007_bib0105","doi-asserted-by":"crossref","first-page":"86","DOI":"10.1186\/s13550-021-00828-0","article-title":"Quantitative SPECT\/CT parameters of myocardial 99mTechnetium-3,3-diphosphono-1,2-propanodicarboxylic acid (DPD) uptake in suspected cardiac transthyretin amyloidosis","volume":"11","author":"Ben-Haim","year":"2021","journal-title":"EJNMMI Res"},{"issue":"3","key":"10.1016\/j.remnie.2023.04.007_bib0110","doi-asserted-by":"crossref","first-page":"1021","DOI":"10.1007\/s12350-020-02396-7","article-title":"Prognostic significance of incidental suspected transthyretin amyloidosis on routine bone scintigraphy","volume":"29","author":"Suomalainen","year":"2022","journal-title":"J Nucl Cardiol"},{"key":"10.1016\/j.remnie.2023.04.007_bib0115","first-page":"G","article-title":"Prevalence and prognostic significance of right ventricule uptake (biventricular uptake) at planar scintigraphy in patients with ATTR cardiac amyloidosis","volume":"23","author":"Porcari","year":"2021","journal-title":"EHJ Suppl"}],"container-title":["Revista Espa\u00f1ola de Medicina Nuclear e Imagen Molecular (English Edition)"],"original-title":[],"language":"en","link":[{"URL":"https:\/\/api.elsevier.com\/content\/article\/PII:S2253808923000393?httpAccept=text\/xml","content-type":"text\/xml","content-version":"vor","intended-application":"text-mining"},{"URL":"https:\/\/api.elsevier.com\/content\/article\/PII:S2253808923000393?httpAccept=text\/plain","content-type":"text\/plain","content-version":"vor","intended-application":"text-mining"}],"deposited":{"date-parts":[[2025,11,6]],"date-time":"2025-11-06T08:45:10Z","timestamp":1762418710000},"score":1,"resource":{"primary":{"URL":"https:\/\/linkinghub.elsevier.com\/retrieve\/pii\/S2253808923000393"}},"subtitle":[],"short-title":[],"issued":{"date-parts":[[2023,9]]},"references-count":23,"journal-issue":{"issue":"5","published-print":{"date-parts":[[2023,9]]}},"alternative-id":["S2253808923000393"],"URL":"https:\/\/doi.org\/10.1016\/j.remnie.2023.04.007","relation":{},"ISSN":["2253-8089"],"issn-type":[{"type":"print","value":"2253-8089"}],"subject":[],"published":{"date-parts":[[2023,9]]},"assertion":[{"value":"Elsevier","name":"publisher","label":"This article is maintained by"},{"value":"Absolute quantification of myocardial uptake of 99mTc-DPD in patients with cardiac amyloidosis due to transthyretin deposits (ATTR)","name":"articletitle","label":"Article Title"},{"value":"Revista Espa\u00f1ola de Medicina Nuclear e Imagen Molecular (English Edition)","name":"journaltitle","label":"Journal Title"},{"value":"https:\/\/doi.org\/10.1016\/j.remnie.2023.04.007","name":"articlelink","label":"CrossRef DOI link to publisher maintained version"},{"value":"https:\/\/doi.org\/10.1016\/j.remn.2023.04.003","name":"associatedlink","label":"CrossRef DOI link to the associated document"},{"value":"article","name":"content_type","label":"Content Type"},{"value":"\u00a9 2023 Sociedad Espa\u00f1ola de Medicina Nuclear e Imagen Molecular. Published by Elsevier Espa\u00f1a, S.L.U. All rights reserved.","name":"copyright","label":"Copyright"}]}}